ACADIA Pharmaceuticals Inc. (ACAD)

ACADIA Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	30.57	-61.29	-215.98	-167.87	-281.58	-235.26
Depreciation & Amortization	11.46	5.55	2.03	3.34	2.93	2.77
Loss (Gain) From Sale of Assets	-	-	-	-	0.28	0
Asset Writedown & Restructuring Costs	-	-	-	-	44.28	-
Loss (Gain) From Sale of Investments	-9	-12.12	-6.28	0.08	2.47	-4.61
Stock-Based Compensation	67	66.42	68.2	63.62	84.42	82.27
Change in Accounts Receivable	-21.85	-36.07	2.17	-16.12	-12.47	-9.69
Change in Inventory	-70.08	-28.81	2.42	-4.21	-3.32	-1.74
Change in Accounts Payable	1.07	4.8	5.87	-1.62	1.27	4.06
Change in Other Net Operating Assets	71.37	78.22	27.54	-2.88	25.55	11.08
Operating Cash Flow	80.53	16.7	-114.04	-125.66	-136.17	-151.13
Capital Expenditures	-0.05	-0.05	-	-1.12	-7.59	-1.13
Sale (Purchase) of Intangibles	-	-40	-	-	-	-
Investment in Securities	-36.42	72.05	73.24	-69.98	200.1	-164.71
Investing Cash Flow	-36.47	32	73.24	-71.1	192.51	-165.84
Issuance of Common Stock	22.79	25.13	8.2	18.16	81	371.85
Financing Cash Flow	22.79	25.13	8.2	18.16	81	371.85
Foreign Exchange Rate Adjustments	-0.01	-0.02	0.01	0.01	-0.01	0
Net Cash Flow	66.84	73.81	-32.59	-178.59	137.33	54.88
Free Cash Flow	80.48	16.65	-114.04	-126.78	-143.75	-152.26
Free Cash Flow Margin	9.04%	2.29%	-22.05%	-26.19%	-32.54%	-44.90%
Free Cash Flow Per Share	0.49	0.10	-0.71	-0.79	-0.91	-1.03
Cash Income Tax Paid	5.85	5.85	2.19	1.04	1.11	1.6
Levered Free Cash Flow	130.44	28.44	-34.96	-65.26	-59.7	-68.6
Unlevered Free Cash Flow	130.44	28.44	-34.96	-65.26	-59.7	-68.6
Change in Net Working Capital	-37.77	-42.38	-34.56	24.58	-6.65	-1.59

Source: S&P Capital IQ. Standard template. Financial Sources.